Evidence map›Paper›PMID 36899433›Full record

ArticleDiabetology & metabolic syndrome2023

Mortality prediction in patients with hyperglycaemic crisis using explainable machine learning: a prospective, multicentre study based on tertiary hospitals.

Puguang Xie, Cheng Yang, Gangyi Yang, Youzhao Jiang, Min He, Xiaoyan Jiang, Yan Chen, Liling Deng, Min Wang, David G Armstrong and 2 more

Full text read
In one paragraph

Article in Diabetology & metabolic syndrome, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Puguang XieDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
Cheng YangDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
Gangyi YangDepartment of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China.
Youzhao JiangDepartment of Endocrinology, People's Hospital of Chongqing Banan District, Chongqing, 401320, China.
Min HeGeneral Practice Department, Chongqing Southwest Hospital, Chongqing, 400038, China.
Xiaoyan JiangDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
Yan ChenDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
Liling DengDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
Min WangDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China.
David G ArmstrongDepartment of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, CA, 90033, USA.
Yu MaDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China. 81846846@qq.com.ORCID http://orcid.org/0000-0003-2175-3346
Wuquan DengDepartment of Endocrinology and Bioengineering College, Chongqing University Central Hospital, Chongqing Emergency Medical Centre, Chongqing University, NO. 1 Jiankang Road, Yuzhong District, Chongqing, 400014, China. wuquandeng@cqu.edu.cn.ORCID http://orcid.org/0000-0002-9883-5051

Funding

Improving the science of adherence reinforcement and safe mobility in people with diabetic foot ulcers using smart offloadingR01DK124789 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARMSTRONG, DAVID GEORGE, NAJAFI, BIJAN · 2021 to 2025
$2.0M
NIDDK NIH HHS R01 DK124789
6 · The paper itself

Abstract

backgroundExperiencing a hyperglycaemic crisis is associated with a short- and long-term increased risk of mortality. We aimed to develop an explainable machine learning model for predicting 3-year mortality and providing individualized risk factor assessment of patients with hyperglycaemic crisis after admission.

methodsBased on five representative machine learning algorithms, we trained prediction models on data from patients with hyperglycaemic crisis admitted to two tertiary hospitals between 2016 and 2020. The models were internally validated by tenfold cross-validation and externally validated using previously unseen data from two other tertiary hospitals. A SHapley Additive exPlanations algorithm was used to interpret the predictions of the best performing model, and the relative importance of the features in the model was compared with the traditional statistical test results.

resultsA total of 337 patients with hyperglycaemic crisis were enrolled in the study, 3-year mortality was 13.6% (46 patients). 257 patients were used to train the models, and 80 patients were used for model validation. The Light Gradient Boosting Machine model performed best across testing cohorts (area under the ROC curve 0.89 [95% CI 0.77-0.97]). Advanced age, higher blood glucose and blood urea nitrogen were the three most important predictors for increased mortality.

conclusionThe developed explainable model can provide estimates of the mortality and visual contribution of the features to the prediction for an individual patient with hyperglycaemic crisis. Advanced age, metabolic disorders, and impaired renal and cardiac function were important factors that predicted non-survival. TRIAL REGISTRATION NUMBER: ChiCTR1800015981, 2018/05/04.

Indexed as

Explainable modelHyperglycaemic crisisMachine learningMortality

Identifiers

PMID36899433
PMCPMC10007769

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read14
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.